Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Idexx Laboratories (IDXX)

IDEXX Laboratories Elects Former State Street CEO Jay Hooley to Board

Neutral Impact 2 of 5 leadership Written later

IDEXX Laboratories added Joseph L. (Jay) Hooley, former Chair and CEO of State Street Corporation, as an independent director effective July 10, 2025. The board expanded from nine to ten directors, and Mr. Hooley joined the Audit Committee and the Governance and Corporate Responsibility Committee. The filing reports no financial results or guidance changes; the appointment is a board governance change.

Key points

  • Joseph L. (Jay) Hooley elected as an independent Class III Director effective July 10, 2025
  • Board size increased from nine to ten directors; Class III seats increased from three to four
  • Appointed to the Audit Committee and Governance and Corporate Responsibility Committee
  • Director stock grants to Mr. Hooley scheduled for September 1, 2025, prorated to the 2026 annual meeting

The filing

CompanyIdexx Laboratories (IDXX)
Form8-K, current report
Filed with the SECJul 10, 2025, 7:00 AM ET
Accession number0001104659-25-066840

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 10, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.